Related Experiment Videos
Follicular basal cell hyperplasia overlying dermatofibroma
L Cheng1, S B Amini, M Tarif Zaim
1Dermatopathology Laboratory, Case Western Reserve University, Cleveland, Ohio 44106, USA.
The American Journal of Surgical Pathology
|June 1, 1997
Summary
Follicular basal cell hyperplasia (FBCH) overlying dermatofibroma is often mistaken for basal cell carcinoma but represents hair follicle differentiation. FBCH is associated with specific clinical and histological features, aiding in its accurate diagnosis.
Area of Science:
- Dermatopathology
- Oncology
- Histology
Background:
- Follicular basal cell hyperplasia (FBCH) overlying dermatofibroma is a distinct entity.
- Historically, FBCH has been misdiagnosed as basal cell carcinoma.
- Understanding FBCH is crucial for accurate dermatologic diagnosis.
Purpose of the Study:
- To differentiate FBCH from basal cell carcinoma.
- To identify clinicopathologic features associated with FBCH.
- To elucidate the nature of FBCH as a manifestation of follicular differentiation.
Main Methods:
- Retrospective analysis of 258 dermatofibroma cases.
- Comparison of 59 cases with FBCH to 199 cases without FBCH.
- Statistical analysis of clinicopathologic features.
Main Results:
- FBCH was linked to younger age, trunk location, hypercellularity, loss of Grenz zone, clear cell hyperplasia, and seborrheic keratosis-like changes.
- Epidermal atrophy, lichen simplex chronicus-like change, and lower extremity location were inversely correlated with FBCH.
- Histologic findings differentiating FBCH from basal cell carcinoma include focal nature, superficial location, lack of atypia, and presence of follicular differentiation components.
Conclusions:
- FBCH represents aborted or impeded follicular differentiation overlying dermatofibroma.
- Clear cell hyperplasia and seborrheic keratosis-like changes are expressions of follicular differentiation in this context.
- Accurate differentiation of FBCH from basal cell carcinoma is essential for appropriate patient management.